Assessing the Effectiveness of a Multiple-micronutrient Fortified Maize Pap on the Nutrient Status of Nigerian School-aged Children
1 other identifier
interventional
934
1 country
1
Brief Summary
A new product was developed by FrieslandCampina for Sub-Saharan Africa as affordable nutrition to nourish Nigerian families of low to middle-socioeconomic class (SEC). It can potentially be used to enhance the ongoing school feeding programs, which are aimed at reducing malnutrition, including micronutrient deficiencies. The main component of the product is maize, which is a traditional staple in Nigeria. The product also contains milk (being a good source of high quality protein) fortified with various micronutrients including iron, iodine, zinc, vitamin A and vitamin B12 at levels contributing to approximately 1/3 of daily recommended intakes per serving of product. Intake of this product may therefore contribute to improvement of micronutrient status among Nigerian schoolchildren suffering from such nutrient deficiencies. Micronutrients are important for various processes in the body, which in turn may influence other outcomes as cognitive performance, reduce illness and improve growth.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 17, 2024
CompletedStudy Start
First participant enrolled
January 24, 2024
CompletedFirst Posted
Study publicly available on registry
February 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 2, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 2, 2024
CompletedJuly 28, 2025
July 1, 2025
6 months
January 17, 2024
July 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Iron status
There will be a change between the two test groups and the control group in iron status as measured by in hemoglobin (whole blood) g/L .
5 months
Serum ferritin
There will be a change between the two test groups and the control group in iron status as measured by serum ferritin (ug/L).
5 months
Secondary Outcomes (2)
Iron deficiency, iron deficiency anaemia and anemia
5 months
Nutrient status
5 months
Other Outcomes (3)
Cognitive performance
5 months
Anthropometric scores
5 months
Illness
5 months
Study Arms (3)
Low dose multiple micronutrient fortification
PLACEBO COMPARATORMaize, milk plus low multiple micronutrient fortification
Moderate dose multiple micronutrient fortification
ACTIVE COMPARATORMaize, milk plus moderate multiple micronutrient fortification
High dose multiple micronutrient fortification
ACTIVE COMPARATORMaize, milk plus high multiple micronutrient fortification (double the moderate level)
Interventions
The study product is a multiple micronutrient fortified maize pap with milk
Eligibility Criteria
You may qualify if:
- Nigerian children in primary schools, aged 5-8 years
- Willing and able to consume the supplied servings of the study product/s or provided control pap
- Having written and oral informed consent from the parent/legal guardian and the participants gave oral and/or written assent.
You may not qualify if:
- Children suffering from severe malnutrition and/or micronutrient deficiencies defined as (such children will be referred to a nearby health centre for appropriate treatment).
- Children with Height-for-age (HAZ) and Weight-for-age (WAZ) \<- 3 Standard Deviation (SD)
- Children showing clinical signs of severe (chronic) anemia i.e. visibly pale, jaundice and lethargic.
- Children with a history of or who at the time of recruitment suffer from chronic illness, including (but not limited to) renal diseases, thyroid disease, (metabolic) bone disease, genetic and/or congenital disorders e.g. Down syndrome and sickle cell anaemia, hepatic dysfunction, thalassemia or chronic diarrhea (e.g. irritable bowl syndrome). Based on medical history examination.
- Children with a physical disability or handicap that prevents participation in the study.
- Children with food allergies or intolerances.
- Children participating in any other clinical research (or having participated in any such study in the previous half year).
- Children or a child's family who are intending to withdraw from school or move out of the study region within the study period.
- Children consuming prescribed 'iron/folic acid, and (multi-)vitamin, and mineral supplements' during the course of the study within the last 2 months prior to the study as a minimum.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- FrieslandCampinalead
- University of Ibadancollaborator
Study Sites (1)
FrieslandCampina Research and Development
Wageningen, 6708 WH, Netherlands
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 17, 2024
First Posted
February 9, 2024
Study Start
January 24, 2024
Primary Completion
August 2, 2024
Study Completion
August 2, 2024
Last Updated
July 28, 2025
Record last verified: 2025-07